Drug Recall: Doctor D. Schwab Controlling Cream Due to Manufacturing Deviations
Doctor D. Schwab Controlling Cream with benzoyl peroxide is being recalled due to manufacturing practice deviations. The voluntary recall affects 470 tubes distributed across multiple U.S. states.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II drug recall with no reported illnesses or injuries. The recall is voluntary and firm-initiated for manufacturing practice deviations, consistent with precautionary recalls.
Plain-English summary
Doctor D. Schwab Controlling Cream, a topical acne treatment containing benzoyl peroxide 2.7%, is being recalled by CA BOTANA International, Inc. due to deviations from current good manufacturing practices (CGMP). The affected product is packaged in 1 fl oz (30 mL) tubes with NDC number 35192-017-05.
The recall affects 470 tubes with lot code D54066 (expiration date 5/31/2027). These tubes were distributed to customers in California, Colorado, Florida, Puerto Rico, and Washington. CA BOTANA initiated the voluntary recall on October 10, 2025, after identifying the manufacturing practice deviations.
Consumers who have purchased this product should stop using it. Contact your pharmacist, physician, or the manufacturer with any questions. Return the product to the place of purchase or dispose of it according to local regulations.
The recalled product
- Product
- Doctor D. Schwab Controlling Cream, Benzoyl Peroxide 2.7%, 1 FL OZ/ 30 ML per tube, Doctor D. Schwab, A division of CA BOTANA, San Diego, CA 92123. NDC: 35192-017-05
- Manufacturer
- CA BOTANA International, Inc.
- Category
- Drug
- Hazard
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot Code D54066
- exp 5/31/2027
Distribution
Distributed in 5 states:
- CA
- CO
- FL
- PR
- WA
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27